GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $609,000 | +39.4% | 50,825 | -2.8% | 0.00% | +100.0% |
| Q2 2022 | $437,000 | -34.0% | 52,266 | -31.5% | 0.00% | 0.0% |
| Q1 2022 | $662,000 | -23.3% | 76,300 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $863,000 | -10.0% | 76,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $959,000 | +54.7% | 76,300 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $620,000 | -12.2% | 76,300 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $706,000 | -8.2% | 76,300 | -4.0% | 0.00% | 0.0% |
| Q4 2020 | $769,000 | -22.1% | 79,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $987,000 | +10.9% | 79,500 | +16.1% | 0.00% | 0.0% |
| Q2 2020 | $890,000 | +32.4% | 68,500 | +3.5% | 0.00% | 0.0% |
| Q1 2020 | $672,000 | +43.3% | 66,200 | +120.7% | 0.00% | +100.0% |
| Q4 2019 | $469,000 | -6.9% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $504,000 | +41.2% | 30,000 | +86.3% | 0.00% | 0.0% |
| Q2 2019 | $357,000 | – | 16,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |